REAGENTS SHOP

ALL REAGENTS SHOP

Filter By

Product Type

Product Category

Target Pathogen

Product Target

Application

SARS-CoV-2, Virus Like Particles (Ha-CoV2) AY.4/BA.1 “Deltacron”

SARS-CoV-2, Virus Like Particles (Ha-CoV2) AY.4/BA.1 “Deltacron” The hybrid alpha-pseudovirus for SARS-CoV-2 (Ha-CoV-2) is a newly developed SARS-CoV-2 virus-like particle (VLP) that encapsulates an alphavirus-derived RNA genome for rapid report expression (luciferase or GFP) in target cells (Hetrick et al., 2022). Different from commonly used S protein pseudotyped lenti- or vesicular stomatitis virus (VSV)-pseudoviruses, Ha-CoV-2 is assembled with all 4 structural proteins (S, M, N, and E) of SARS-CoV-2, and contains a reporter genome derived from an alphavirusbased vector for rapid (6 hours) and robust expression of reporter genes. The alphavirus vector does not contain any of the structural proteins from the authentic virus and the alpha-pseudovirus particles are single-cycle. Spike Mutations: Spike T19R, Spike A27S, Spike T95I, Spike G142D, Spike E156G, Spike F157del, Spike R158del, Spike ins214EPE, Spike N211del, Spike L212I, Spike G339D, Spike S371L, Spike S373P, Spike S375F Spike K417N, Spike N440K, Spike G446S, Spike S477N, Spike T478K, Spike E484A, Spike Q493R, Spike G496S, Spike Q498R, Spike N501Y, Spike Y505H, Spike T547K, Spike D614G, Spike H655Y, Spike N679K, Spike P681H, Spike N764K, Spike D796Y, Spike N856K, Spike Q954H, Spike L981F, Spike N969K Size:

25 X 200 µL ~100 wells/96 well plate
60x Conc. 5 x 100 µL

Reporter: Available with Firefly luciferase, GFP, or RFP Formulation & Storage: Store at -80°C. Intended for research use only, not for human, therapeutic, or diagnostic applications.

Price:

$1,490.00 – $2,350.00

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Delta (B.1.617.2)

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Delta (B.1.617.2): hybrid alpha-pseudovirus for SARS-CoV-2 (Ha-CoV2) for strain Delta (B.1.617.2) The hybrid alpha-pseudovirus for SARS-CoV-2 (Ha-CoV-2) is a newly developed SARS-CoV-2 virus-like particle (VLP) that encapsulates an alphavirus-derived RNA genome for rapid report expression (luciferase or GFP) in target cells (Hetrick et al., 2022). Different from commonly used S protein pseudotyped lenti- or vesicular stomatitis virus (VSV)-pseudoviruses, Ha-CoV-2 is assembled with all 4 structural proteins (S, M, N, and E) of SARS-CoV-2, and contains a reporter genome derived from an alphavirusbased vector for rapid (6 hours) and robust expression of reporter genes. The alphavirus vector does not contain any of the structural proteins from the authentic virus and the alpha-pseudovirus particles are single-cycle. Spike Mutations: Spike T19R, Spike del157/158, Spike L452R, Spike T478K, Spike D614G, Spike P681R, Spike D950N Size:

25 X 200 µL ~100 wells/96 well plate
60x Conc. 5 x 100 µL

Reporter: Available with Firefly luciferase, GFP, or RFP Formulation & Storage: Store at -80°C. Intended for research use only, not for human, therapeutic, or diagnostic applications.

Price:

$1,490.00 – $2,350.00

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Delta Plus (AY4.2)

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Delta Plus (AY4.2) The hybrid alpha-pseudovirus for SARS-CoV-2 (Ha-CoV-2) is a newly developed SARS-CoV-2 virus-like particle (VLP) that encapsulates an alphavirus-derived RNA genome for rapid report expression (luciferase or GFP) in target cells (Hetrick et al., 2022). Different from commonly used S protein pseudotyped lenti- or vesicular stomatitis virus (VSV)-pseudoviruses, Ha-CoV-2 is assembled with all 4 structural proteins (S, M, N, and E) of SARS-CoV-2, and contains a reporter genome derived from an alphavirusbased vector for rapid (6 hours) and robust expression of reporter genes. The alphavirus vector does not contain any of the structural proteins from the authentic virus and the alpha-pseudovirus particles are single-cycle. Spike Mutations: Spike T19R, Spike T95I, Spike G142D, Spike Y145H, Spike E156G, Spike del157/158, Spike A222V, Spike L452R, Spike T478K, Spike D614G, Spike P681R, Spike D950N Size:

25 X 200 µL ~100 wells/96 well plate
60x Conc. 5 x 100 µL

Reporter: Available with Firefly luciferase, GFP, or RFP Formulation & Storage: Store at -80°C. Intended for research use only, not for human, therapeutic, or diagnostic applications.

Price:

$1,490.00 – $2,350.00

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Epsilon (B.1.427/429)

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Epsilon (B.1.427/429) : hybrid alpha-pseudovirus for SARS-CoV-2 (Ha-CoV2) for strain Epsilon (B.1.427/429) The hybrid alpha-pseudovirus for SARS-CoV-2 (Ha-CoV-2) is a newly developed SARS-CoV-2 virus-like particle (VLP) that encapsulates an alphavirus-derived RNA genome for rapid report expression (luciferase or GFP) in target cells (Hetrick et al., 2022). Different from commonly used S protein pseudotyped lenti- or vesicular stomatitis virus (VSV)-pseudoviruses, Ha-CoV-2 is assembled with all 4 structural proteins (S, M, N, and E) of SARS-CoV-2, and contains a reporter genome derived from an alphavirusbased vector for rapid (6 hours) and robust expression of reporter genes. The alphavirus vector does not contain any of the structural proteins from the authentic virus and the alpha-pseudovirus particles are single-cycle. Spike Mutations: Spike D614G, Spike E484K, Spike L452R, Spike S13I, Spike W152C Size:

25 X 200 µL ~100 wells/96 well plate
60x Conc. 5 x 100 µL

Reporter: Available with Firefly luciferase, GFP, or RFP Formulation & Storage: Store at -80°C. Intended for research use only, not for human, therapeutic, or diagnostic applications.

Price:

$1,490.00 – $2,350.00

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Epsilon (B.1.429)

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Epsilon (B.1.429) The hybrid alpha-pseudovirus for SARS-CoV-2 (Ha-CoV-2) is a newly developed SARS-CoV-2 virus-like particle (VLP) that encapsulates an alphavirus-derived RNA genome for rapid report expression (luciferase or GFP) in target cells (Hetrick et al., 2022). Different from commonly used S protein pseudotyped lenti- or vesicular stomatitis virus (VSV)-pseudoviruses, Ha-CoV-2 is assembled with all 4 structural proteins (S, M, N, and E) of SARS-CoV-2, and contains a reporter genome derived from an alphavirusbased vector for rapid (6 hours) and robust expression of reporter genes. The alphavirus vector does not contain any of the structural proteins from the authentic virus and the alpha-pseudovirus particles are single-cycle. Spike Mutations: Spike A222V, Spike D614G, Spike L452R, Spike S13I, Spike W152C Size:

25 X 200 µL ~100 wells/96 well plate
60x Conc. 5 x 100 µL

Reporter: Available with Firefly luciferase, GFP, or RFP Formulation & Storage: Store at -80°C. Intended for research use only, not for human, therapeutic, or diagnostic applications.

Price:

$1,490.00 – $2,350.00

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Eta (B.1.525)

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Eta (B.1.525) : hybrid alpha-pseudovirus for SARS-CoV-2 (Ha-CoV2) for strain Eta (B.1.525) The hybrid alpha-pseudovirus for SARS-CoV-2 (Ha-CoV-2) is a newly developed SARS-CoV-2 virus-like particle (VLP) that encapsulates an alphavirus-derived RNA genome for rapid report expression (luciferase or GFP) in target cells (Hetrick et al., 2022). Different from commonly used S protein pseudotyped lenti- or vesicular stomatitis virus (VSV)-pseudoviruses, Ha-CoV-2 is assembled with all 4 structural proteins (S, M, N, and E) of SARS-CoV-2, and contains a reporter genome derived from an alphavirusbased vector for rapid (6 hours) and robust expression of reporter genes. The alphavirus vector does not contain any of the structural proteins from the authentic virus and the alpha-pseudovirus particles are single-cycle. Spike Mutations: Spike A67V, Spike D614G, Spike E484K, Spike F888L, Spike H69del, Spike Q52R, Spike Q677H, Spike V70del, Spike Y144del Size:

25 X 200 µL ~100 wells/96 well plate
60x Conc. 5 x 100 µL

Reporter: Available with Firefly luciferase, GFP, or RFP Formulation & Storage: Store at -80°C. Intended for research use only, not for human, therapeutic, or diagnostic applications.

Price:

$1,490.00 – $2,350.00

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Gamma (P.1)

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Gamma (P.1) The hybrid alpha-pseudovirus for SARS-CoV-2 (Ha-CoV-2) is a newly developed SARS-CoV-2 virus-like particle (VLP) that encapsulates an alphavirus-derived RNA genome for rapid report expression (luciferase or GFP) in target cells (Hetrick et al., 2022). Different from commonly used S protein pseudotyped lenti- or vesicular stomatitis virus (VSV)-pseudoviruses, Ha-CoV-2 is assembled with all 4 structural proteins (S, M, N, and E) of SARS-CoV-2, and contains a reporter genome derived from an alphavirusbased vector for rapid (6 hours) and robust expression of reporter genes. The alphavirus vector does not contain any of the structural proteins from the authentic virus and the alpha-pseudovirus particles are single-cycle. Spike Mutations: Spike D138Y, Spike D614G, Spike E484K, Spike H655Y, Spike K417T, Spike L18F, Spike N501Y, Spike P26S, Spike R190S, Spike T20N, Spike T1027I, Spike V1176F Size:

25 X 200 µL ~100 wells/96 well plate
60x Conc. 5 x 100 µL

Reporter: Available with Firefly luciferase, GFP, or RFP Formulation & Storage: Store at -80°C. Intended for research use only, not for human, therapeutic, or diagnostic applications.

Price:

$1,490.00 – $2,350.00

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Kappa (B.1.617.1)

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Kappa (B.1.617.1) The hybrid alpha-pseudovirus for SARS-CoV-2 (Ha-CoV-2) is a newly developed SARS-CoV-2 virus-like particle (VLP) that encapsulates an alphavirus-derived RNA genome for rapid report expression (luciferase or GFP) in target cells (Hetrick et al., 2022). Different from commonly used S protein pseudotyped lenti- or vesicular stomatitis virus (VSV)-pseudoviruses, Ha-CoV-2 is assembled with all 4 structural proteins (S, M, N, and E) of SARS-CoV-2, and contains a reporter genome derived from an alphavirusbased vector for rapid (6 hours) and robust expression of reporter genes. The alphavirus vector does not contain any of the structural proteins from the authentic virus and the alpha-pseudovirus particles are single-cycle. Spike Mutations: Spike E154K, Spike L452R, Spike E484Q, Spike D614G, Spike P681R, Spike Q1071H Size:

25 X 200 µL ~100 wells/96 well plate
60x Conc. 5 x 100 µL

Reporter: Available with Firefly luciferase, GFP, or RFP Formulation & Storage: Store at -80°C. Intended for research use only, not for human, therapeutic, or diagnostic applications.

Price:

$1,490.00 – $2,340.00

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Lambda (C.37)

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Lambda (C.37) The hybrid alpha-pseudovirus for SARS-CoV-2 (Ha-CoV-2) is a newly developed SARS-CoV-2 virus-like particle (VLP) that encapsulates an alphavirus-derived RNA genome for rapid report expression (luciferase or GFP) in target cells (Hetrick et al., 2022). Different from commonly used S protein pseudotyped lenti- or vesicular stomatitis virus (VSV)-pseudoviruses, Ha-CoV-2 is assembled with all 4 structural proteins (S, M, N, and E) of SARS-CoV-2, and contains a reporter genome derived from an alphavirusbased vector for rapid (6 hours) and robust expression of reporter genes. The alphavirus vector does not contain any of the structural proteins from the authentic virus and the alpha-pseudovirus particles are single-cycle. Spike Mutations: Spike G75V, Spike T76I, Spike R246N, Spike del247/253, Spike L452Q, Spike F490S, Spike D614G, Spike T859N Size:

25 X 200 µL ~100 wells/96 well plate
60x Conc. 5 x 100 µL

Reporter: Available with Firefly luciferase, GFP, or RFP Formulation & Storage: Store at -80°C. Intended for research use only, not for human, therapeutic, or diagnostic applications.

Price:

$1,490.00 – $2,350.00

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Mu (B.1.621)

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Mu (B.1.621) The hybrid alpha-pseudovirus for SARS-CoV-2 (Ha-CoV-2) is a newly developed SARS-CoV-2 virus-like particle (VLP) that encapsulates an alphavirus-derived RNA genome for rapid report expression (luciferase or GFP) in target cells (Hetrick et al., 2022). Different from commonly used S protein pseudotyped lenti- or vesicular stomatitis virus (VSV)-pseudoviruses, Ha-CoV-2 is assembled with all 4 structural proteins (S, M, N, and E) of SARS-CoV-2, and contains a reporter genome derived from an alphavirusbased vector for rapid (6 hours) and robust expression of reporter genes. The alphavirus vector does not contain any of the structural proteins from the authentic virus and the alpha-pseudovirus particles are single-cycle. Spike Mutations: Spike T95I, Spike Y144S, Spike Y145N, Spike R346K, Spike E484K, Spike N501Y, Spike D614G, Spike P681H, Spike D950N Size:

25 X 200 µL ~100 wells/96 well plate
60x Conc. 5 x 100 µL

Reporter: Available with Firefly luciferase, GFP, or RFP Formulation & Storage: Store at -80°C. Intended for research use only, not for human, therapeutic, or diagnostic applications.

Price:

$1,490.00 – $2,350.00

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Omicron (B.1.1.529)

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Omicron (B.1.1.529) The hybrid alpha-pseudovirus for SARS-CoV-2 (Ha-CoV-2) is a newly developed SARS-CoV-2 virus-like particle (VLP) that encapsulates an alphavirus-derived RNA genome for rapid report expression (luciferase or GFP) in target cells (Hetrick et al., 2022). Different from commonly used S protein pseudotyped lenti- or vesicular stomatitis virus (VSV)-pseudoviruses, Ha-CoV-2 is assembled with all 4 structural proteins (S, M, N, and E) of SARS-CoV-2, and contains a reporter genome derived from an alphavirusbased vector for rapid (6 hours) and robust expression of reporter genes. The alphavirus vector does not contain any of the structural proteins from the authentic virus and the alpha-pseudovirus particles are single-cycle. Spike Mutations: Spike A67V, Spike H69del,Spike V70del, Spike T95I, Spike G142D, Spike V143del, Spike Y144del, Spike Y145del, Spike N211del, Spike L212I, Spike ins214EPE, Spike G339D, Spike S371L, Spike S373P, Spike S375F, Spike K417N, Spike N440K, Spike G446S, Spike S477N, Spike T478K, Spike E484A, Spike Q493R, Spike G496S, Spike Q498R, Spike N501Y, Spike Y505H, Spike T547K, Spike D614G, Spike H655Y, Spike N679K, Spike P681H, Spike N764K, Spike D796Y, Spike N856K, Spike Q954H, Spike N969K, Spike L981F Size:

25 X 200 µL ~100 wells/96 well plate
60x Conc. 5 x 100 µL

Reporter: Available with Firefly luciferase, GFP, or RFP Formulation & Storage: Store at -80°C. Intended for research use only, not for human, therapeutic, or diagnostic applications.

Price:

$1,490.00 – $2,350.00

SARS-CoV-2, Virus Like Particles (Wild Type)

The hybrid alpha-pseudovirus for SARS-CoV-2 (Ha-CoV-2) is a newly developed SARS-CoV-2 virus-like particle (VLP) that encapsulates an alphavirus-derived RNA genome for rapid report expression (luciferase or GFP) in target cells (Hetrick et al., 2022). Different from commonly used S protein pseudotyped lenti- or vesicular stomatitis virus (VSV)-pseudoviruses, Ha-CoV-2 is assembled with all 4 structural proteins (S, M, N, and E) of SARS-CoV-2, and contains a reporter genome derived from an alphavirusbased vector for rapid (6 hours) and robust expression of reporter genes. The alphavirus vector does not contain any of the structural proteins from the authentic virus and the alpha-pseudovirus particles are single-cycle. Size(s):

25 X 200 µL ~100 wells/96 well plate
60x Conc. 5 x 100 µL

Reporter: Available with Firefly luciferase, GFP, or RFP Formulation & Storage: Available upon request. Store at -80°C. Intended for research use only, not for human, therapeutic, or diagnostic applications

Price:

$1,490.00 – $2,350.00

SARS-CoV2 Nucleocapsid Protein

SARS-CoV2 Nucleocapsid protein (N protein) is supplied as purified protein.

His-tagged
SARS-CoV2 N is produced in E. coli.
Purified by FPLC

Formulation & Storage: Supplied in HEPES buffer with sodium salt. Store at -20°C for 2-3 weeks, -80°C for long term.

Notes & Usage Guidelines: ELISA: Assay-dependent dilution WB: Assay-dependent dilution

SARS-CoV2 N is intended for research use only, not for human, therapeutic, or diagnostic applications.

Price:

$518.00

SARS-CoV2 Receptor Binding Domain (RBD)

SARS-CoV2 Receptor Binding Domain (RBD) with His-tag is supplied as purified protein.

His-tagged
SARS-CoV2 RBD is produced in stably transfected Drosophila Schneider 2 (S2) cells
Purified by FPLC

Formulation & Storage: Supplied in HEPES buffer with sodium salt. Store at -20°C for 2-3 weeks, -80°C for long term.

Notes & Usage Guidelines: ELISA: Assay-dependent dilution WB: Assay-dependent dilution

SARS-CoV2 RBD is intended for research use only, not for human, therapeutic, or diagnostic applications.

Price:

$518.00

SARS-CoV2, Full-Length Spike Protein (S1+S2, ECD)

SARS-CoV2 Full-Length Spike Protein (S1+S2, stabilized ectodomain) is supplied as purified protein.

His-tagged
SARS-CoV2 S1+S2, ECD is produced in stably transfected Drosophila Schneider 2 (S2) cells.
Purified by FPLC

Formulation & Storage: Supplied in PBS and supplemented with glycerol, arginine and glutamic acid. Store at -80°C for long term.

Notes & Usage Guidelines: ELISA: Assay-dependent dilution WB: Assay-dependent dilution

SARS-CoV2 S1+S2, ECD is intended for research use only, not for human, therapeutic, or diagnostic applications.

Price:

$518.00

Staphylococcus Aureus Csa1A Polyclonal Antibody

Staphylococcus Aureus Csa1A Polyclonal Antibody; A rabbit polyclonal antibody broadly reactive to Csa1A. This antibody is ideal for studying Staphylococcus aureus, particularly the USA300 strain, and is useful in various applications such as Western Blot.

Immunogen/ Target: Conserved Staph Antigen 1A (Csa1A) peptide polyclonal (GYRDDQFDKNDKGTC).
Formulation & Storage: Supplied in PBS. Store at +4°C for 2-3 weeks, -80°C for long term
Certificate of analysis: A hardcopy of datasheet is sent along with the products. Please refer to it for detailed information.
This antibody is intended for research use only, not for human, therapeutic, or diagnostic applications

Price:

$394.00

Staphylococcus aureus EsxA pAb

Staphylococcus aureus EsxA pAb is a rabbit polyclonal antibody broadly reactive to EsxA His-6. This antibody is designed to target the Ess extracellular protein A of Staphylococcus aureus, making it a valuable tool for research involving this pathogen. The immunogen is the EsxA His-6 peptide polyclonal (MSPEEIRAKSQSYGC).

Immunogen/ Target: Staphylococcus aureus Ess extracellular protein A (EsxA) His-6 peptide polyclonal (MSPEEIRAKSQSYGC).
Formulation & Storage: Supplied in PBS. Store at +4°C for 2-3 weeks, -80°C for long term
Certificate of analysis: A hardcopy of datasheet is sent along with the products. Please refer to it for detailed information.
This antibody is intended for research use only, not for human, therapeutic, or diagnostic applications

Price:

$394.00

Staphylococcus aureus EsxB pAb

Staphylococcus aureus EsxB pAb is a rabbit polyclonal antibody reactive to EsxB His6. The immunogen is Staphylococcus aureus Ess extracellular protein B (EsxB) His6 peptide polyclonal (GGYKGIKADGGKVDC). The pathogen strain is Staphylococcus aureus USA300, and the product is affinity purified.

Immunogen/ Target: Staphylococcus aureus Ess extracellular protein B (EsxB) His6 peptide polyclonal (GGYKGIKADGGKVDC).
Formulation & Storage: Supplied in PBS. Store at +4°C for 2-3 weeks, -80°C for long term.
Certificate of analysis: A hardcopy of datasheet is sent along with the products. Please refer to it for detailed information.
This antibody is intended for research use only, not for human, therapeutic, or diagnostic applications

Price:

$394.00

SARS-CoV-2 Virus Like Particles (Ha-CoV2) Delta Plus (AY.2)

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Epsilon (B.1.427/429)

SARS-CoV-2, Virus Like Particles (Ha-CoV2) (B.1.1.298)

SARS-CoV-2, Virus Like Particles (Alpha (B.1.1.7))

Sudan virus-like particles (SUDV VLP)

REAGENTS SHOP

ALL REAGENTS SHOP

Filter By

Product Type

Product Category

Target Pathogen

Product Target

Application

Price:

Price:

Price:

Price:

Price:

Price:

Price:

Price:

Price:

Price:

Price:

Price:

Price:

Price:

Price:

Price:

Price:

Price:

FEATURED PRODUCTS

Related products

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Delta (B.1.617.2)

SARS-CoV-2, Virus Like Particles (Ha-CoV2) Eta (B.1.525)

SARS-CoV-2, Virus Like Particles (Ha-CoV2) (B.1.1.298)

Marburg-Musoke virus-like particles (MMARV VLP)

Sign up for our newsletter

Media

Services By Disease Target